SI1118619T1 - Method to identify agents active against HCV by using the structure coordinates of hepatitis C virus protease - Google Patents

Method to identify agents active against HCV by using the structure coordinates of hepatitis C virus protease

Info

Publication number
SI1118619T1
SI1118619T1 SI9730574T SI9730574T SI1118619T1 SI 1118619 T1 SI1118619 T1 SI 1118619T1 SI 9730574 T SI9730574 T SI 9730574T SI 9730574 T SI9730574 T SI 9730574T SI 1118619 T1 SI1118619 T1 SI 1118619T1
Authority
SI
Slovenia
Prior art keywords
hepatitis
active against
structure coordinates
identify agents
against hcv
Prior art date
Application number
SI9730574T
Other languages
Slovenian (sl)
Inventor
Joseph L. Kim
Kurt A. Morgenstern
Chao Lin
Ted Fox
John A. THOMSON
Original Assignee
Vertex Pharmaceuticals Incorporated
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/731,336 external-priority patent/US6153579A/en
Application filed by Vertex Pharmaceuticals Incorporated filed Critical Vertex Pharmaceuticals Incorporated
Priority claimed from EP01101009A external-priority patent/EP1118619B1/en
Publication of SI1118619T1 publication Critical patent/SI1118619T1/en

Links

SI9730574T 1996-09-12 1997-09-12 Method to identify agents active against HCV by using the structure coordinates of hepatitis C virus protease SI1118619T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2527496P 1996-09-12 1996-09-12
US08/731,336 US6153579A (en) 1996-09-12 1996-10-18 Crystallizable compositions comprising a hepatitis C virus NS3 protease domain/NS4A complex
EP01101009A EP1118619B1 (en) 1996-09-12 1997-09-12 Method to identify agents active against HCV by using the structure coordinates of hepatitis C virus protease

Publications (1)

Publication Number Publication Date
SI1118619T1 true SI1118619T1 (en) 2003-12-31

Family

ID=29782973

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9730574T SI1118619T1 (en) 1996-09-12 1997-09-12 Method to identify agents active against HCV by using the structure coordinates of hepatitis C virus protease

Country Status (1)

Country Link
SI (1) SI1118619T1 (en)

Similar Documents

Publication Publication Date Title
AU2933797A (en) Synthetic inhibitors of hepatitis c virus ns3 protease
HK1023779A1 (en) Inhibitors of serine proteases, particularly hepatitis c virus ns3 protease
ID30459A (en) MACROSICLIC PEPTIDES ACTIVE AGAINST HEPATITIS VIRUS C
GB9707659D0 (en) Hepatitis C NS3 Protease inhibitors
AU2055301A (en) Alpha-ketoamide inhibitors of hepatitis c virus ns3 protease
ITRM940092A0 (en) METHODOLOGY TO REPRODUCE IN VITRO THE PROTEOLYTIC ACTIVITY OF THE NS3 PROTEASE OF THE HCV VIRUS.
HK1038573A1 (en) Method to identify agents active against hcv by using the structure coordinates of hepatitis c virus protease
ITMI920162A1 (en) METHOD TO MAINTAIN THE ACTIVITY OF PROTEOLYTIC ENZYMES MODIFIED WITH POLYETHYLENGLYCOL
HU229997B1 (en) Peptides as ns3-serine protease inhibitors of hepatitis c virus
AU6371900A (en) Lactam inhibitors of hepatitis c virus ns3 protease
AU5729196A (en) Soluble, active hepatitis c virus protease
EP0755372A4 (en) Inhibitors of influenza virus neuraminidase and methods of making and using the same
AU1905399A (en) Hepatitis c virus ns5b truncated protein and methods thereof to identify antiviral compounds
SI0932617T1 (en) Inhibitors of serine proteases, particularly hepatitis c virus ns3 protease
EP1141255A4 (en) Modified forms of hepatitis c virus ns3 protease
FI951198A0 (en) New branched hybrid and group peptides effective in the diagnosis and detection of non-A, non-B hepatitis
PH31116A (en) Methods for the treatment of infection caused by hepatitis B virus (hbv).
SI1118619T1 (en) Method to identify agents active against HCV by using the structure coordinates of hepatitis C virus protease
EP1113777A4 (en) Novel hepatitis c virus peptides and uses thereof
EP1068362A4 (en) Hepatitis c virus ns5b compositions and methods of use thereof
AU4397097A (en) Soluble polypeptides with activity of the ns3 serine protease of hepatitis c virus, and process for their preparation and isolation
ZA964094B (en) Compositions and methods for the diagnosis of and vaccination against hepatitis c virus (hcv)
AU7679491A (en) Hepatitis c virus protease inhibitors
IL73973A0 (en) Detection of non-a,non-b hepatitis
GB9425604D0 (en) Peptides effective for diagnsis of hepatitis C infection